We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BCAB market cap is 156.27M. The company's latest EPS is USD -2.5756 and P/E is -1.26.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | -21k | 0 |
| Operating Income | -26.18M | -28.56M | -28.93M | -37.22M | -35.02M |
| Net Income | -25.78M | -27.54M | -27.46M | -35.75M | -33.33M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.2M | 429k | 250k | 0 | 0 |
| Operating Income | -28.27M | -30.1M | -96.44M | -108.14M | -129.69M |
| Net Income | -28.73M | -35.85M | -95.4M | -106.48M | -123.46M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 189.11M | 225.74M | 204.55M | 179.64M | 151.36M |
| Total Liabilities | 46.48M | 45.4M | 48.13M | 55.12M | 56.66M |
| Total Equity | 142.63M | 180.34M | 156.43M | 124.52M | 94.7M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.34M | 244.94M | 254.42M | 225.74M | 119.66M |
| Total Liabilities | 65.35M | 34.96M | 43.6M | 45.4M | 48.99M |
| Total Equity | -56.01M | 209.97M | 210.82M | 180.34M | 70.67M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -66.07M | -90.42M | -22.65M | -46.75M | -74.09M |
| Investing | -234k | -265k | -50k | -65k | -90k |
| Financing | -552k | 61.21M | -116k | -1,000 | -42k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.65M | -36.33M | -62.21M | -90.42M | -104.02M |
| Investing | -1.51M | -590k | -924k | -265k | -98k |
| Financing | 4M | 271.83M | 69.51M | 61.21M | 77k |
| Market Cap | 156.27M |
| Price to Earnings Ratio | -1.26 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.4 |
| Price to Book Ratio | 2.2 |
| Dividend Yield | - |
| Shares Outstanding | 47.94M |
| Average Volume (1 week) | 1.38M |
| Average Volume (1 Month) | 755.84k |
| 52 Week Change | -7.39% |
| 52 Week High | 4.068 |
| 52 Week Low | 1.24 |
| Spread (Intraday) | 0.26 (7.98%) |
| Company Name | BioAtla Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.bioatla.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
